Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Gains from Sales and Divestitures (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Gains from Sales and Divestitures for 12 consecutive years, with $22429.0 as the latest value for Q4 2025.

  • Quarterly Gains from Sales and Divestitures rose 57.22% to $22429.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22429.0 through Dec 2025, up 57.22% year-over-year, with the annual reading at $22429.0 for FY2025, 57.22% up from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $22429.0 at Lemaitre Vascular, up from $14266.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $51414.0 in Q4 2021, with the low at $14266.0 in Q4 2024.
  • Average Gains from Sales and Divestitures over 3 years is $29369.7, with a median of $22429.0 recorded in 2025.
  • The sharpest move saw Gains from Sales and Divestitures rose 1.47% in 2021, then skyrocketed 57.22% in 2025.
  • Over 3 years, Gains from Sales and Divestitures stood at $51414.0 in 2021, then tumbled by 72.25% to $14266.0 in 2024, then surged by 57.22% to $22429.0 in 2025.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $22429.0, $14266.0, and $51414.0 for Q4 2025, Q4 2024, and Q4 2021 respectively.